Advocacy

Federal Officials Propose ASHP-Supported Rules to Expand Coverage for Contraception, PrEP

Published: October 24, 2024
Advocacy Breaking News

This week, the Department of Health and Human Services (HHS) proposed new rules to promote patient access to recommended preventative services, including contraception and pre-exposure prophylaxis (PrEP), at no cost to patients — changes that are consistent with ASHP policy.

The proposed rules, “Enhancing Coverage of Preventive Services Under the Affordable Care Act,” are a joint agency effort by HHS and the Departments of Labor and the Treasury to standardize coverage requirements for preventive services across group health plans and health insurers.

If finalized, the proposal would expand coverage, without cost-sharing, to over-the-counter contraception, including emergency contraception, and prescribed contraception. It would also require increased transparency for patients about coverage of and access to contraception. The rule also expands coverage to all Food and Drug Administration-approved formulations of medications for PrEP, as recommended by the United States Preventive Services Task Force. The proposal provides additional guidance for insurers related to reasonable medical and utilization management techniques for these services.

These actions are consistent with ASHP’s policies, Over-the-Counter Availability of Hormonal Contraceptives and Pharmacist Prescribing Authority for Antiretroviral Therapy for the Prevention of HIV/AIDS, which advocate for coverage policies that ensure patient access to these preventative therapies is not compromised.

“We applaud efforts to increase patient access to hormonal contraception and PrEP,” said Tom Kraus, ASHP vice president of government relations. “We are taking a close look at the proposed rules to ensure that these changes fully incorporate established pharmacist-led access to these important preventative services.”

ASHP will be reviewing and responding to the proposed rules over the next 60 days. We will be carefully evaluating any unintended consequences for patients living in the states that allow pharmacist-prescribed access to contraceptives, PrEP, and other preventative services. Email Anna Legreid Dopp, ASHP senior director of government relations, with questions or concerns about the proposal.

Posted October 24, 2024
ADVERTISEMENT

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information